On track for third quarter 2026 top-line trial results from anticipated pivotal Phase 2b clinical trial (ELPIS II) evaluating laromestrocel as a ...
Recorded a one-time accrued severance cost in 2025 related to the departure of the former CEO. Acknowledged that the PDCM ...
The private placement was led by Coastlands Capital, with participation from Janus Henderson Investors, along with Logos Capital and Kalehua Capital, for total gross proceeds in the initial closing of ...
The family of an 8-year-old girl with a rare heart defect is using their journey to support other families in the same ...
The private placement is led by Coastlands Capital, with participation from Janus Henderson Investors, along with Logos Capital and Kalehua Capital, for total gross proceeds in the initial closing of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results